AltheaDx (IDGX) Stock Price, News & Analysis

Company Overview

AltheaDx, Inc. is a United States-based commercial-stage molecular diagnostics company. The Company is specialized in the field of pharmacogenetics. The Company focuses on enabling physicians, managed care organizations, pharmaceutical companies and other healthcare entities to make personalized therapeutic decisions for patients. The Company's IDgenetix pharmacogenetic testing portfolio addresses various clinical conditions in the United States, including cardiovascular disease, neuropsychiatric disorders and pain. The IDgenetix testing process consists of three steps: drug metabolism genotyping, drug response genotyping and algorithm screening. Its algorithm-based bioinformatic platform and pharmacogenetics product testing portfolio are intended to serve as a tool to assist healthcare providers in identifying optimal drugs for their patients, as well as dosing guidelines based on a patient's genetic make-up, prescription regimen and other key factors.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

IDGX Stock Analysis - Frequently Asked Questions

When did AltheaDx IPO?

AltheaDx (IDGX) raised $60 million in an initial public offering (IPO) on Wednesday, February 11th 2015. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Citigroup and Jefferies served as the underwriters for the IPO and William Blair and Cantor Fitzgerald were co-managers.

What other stocks do shareholders of AltheaDx own?

Based on aggregate information from My MarketBeat watchlists, some other companies that AltheaDx investors own include Workhorse Group (WKHS), Walmart (WMT), Blink Charging (BLNK), Global Blood Therapeutics (GBT), Nano Dimension (NNDM), Riot Platforms (RIOT) and Cassava Sciences (SAVA).

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:IDGX
• CIK: N/A
• Web: www.altheadx.com
• Phone: +1-858-8820123
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A